Eosinophilic Granulomatosis with Polyangiitis Relapse after COVID-19 Vaccination: A Case Report.
Giulia Anna Maria Luigia CostanzoAndrea Giovanni LeddaAlessandra GhisuMatteo VaccaDavide FirinuStefano R Del GiaccoPublished in: Vaccines (2021)
She had a mild COVID-19 in December 2020 and she tested negative for SARS-CoV-2 infection in only late January 2021. In April 2021 she received the first dose of mRNA BNT162b2 vaccine. Ten days later she developed myalgia, dyspnea and numbness of the limbs due to a relapse of EGPA that occurred during Mepolizumab treatment.